Endothelial dysfunction and platelet activation in patient with chronic atrial fibrillation: interactions leading to thrombogenesis?  by Li-Saw-Hee, F. et al.
1-,J L~ 
i:i 
.,:, :.-i 
A 
3' 
P 
0 
1 
E 
R 
302A JACC February 1998 
significantly different between the groups (AF FJ,3 + 3,9 vs non-AF 6,2 ~: 3,4% 
N,8,), 
Conclusion: We concluded that the reduced TM expression on atrial endo- 
cardlum may also contribute to the atrial thrombus formation In patients with 
AF, 
• Endothellnl and PlMelet Activation In Oysfunctlon 
PMlent Wlth Chronl¢ Atrlsl Flbrlllatlon' 
Interactlons Lesdlng to l"hmmhogenuls? 
F, U.Sew.Hee, A,D, Blann, G,Y,H. Lip, Haemosfasls, Thrombosis and 
V~¢'ul~r elolow Urtlt, Unlvemtly D~pl. of Medicine, Th~ City Hrmplfal, 
Btrmlngt~m, Bf8 ~;tH, Unlt~f Kingdom 
Bad~urM: Atrlffl flbflllation II II ~mmon anlhymle whteh le asso01otod with 
Stroke endthmmbcomboUsm, Recent studied have suggested that eiffel fibril, 
lotion oonltm A hypemosgulobte late, However, the thrambotle tendaney el 
blood Is lnfluen0ed by many foctom Including Interaotlon= between endothelial 
cells end pllIolets, 
M~thed~" We pedolmod a oross,seotinnol study ol Indices el platelot and 
endothelial cell kln~tlon In 4~ potlents (31 msleo, mean age ,* 71) with 0hrenlo 
eiffel fibrillation end eompamd them with 4f! Age, and sac,matched ~on, 
tmlll, We meosumd the platalat aotlvstlon marker soluble P-seteotln (e,Poel) 
(ng/tnL) trod endethetl~l markem soluble thrembomodutln (aTM) (nglmL) end 
son Wlllebrand factor (vWF) (IU/dL) by ELISA mP, thods~ 
~u~:  
P~tmnl~l 133 ~1 24 I~5 (lSQ-~9~,) ~4 -1~ 18 
Control 104 .~ ~ ~0~ (ELF-,1901 40 ~: tO 
P vlI~s ,~ 0.01 0,48 4,05 
Conc/u,Won: This study suggests the presence ol endothelial dysfunction in 
pstten~ with atrial fibrillation, as indicated by significant elevation el van WIIle. 
brand fe0for lavela, although the elsvMIon In soluble thrombomedulin was 
only of borderline significance. There was no significant tncreece In soluble 
P,lele¢~ln, although previous studies have Indicated high ptalelet activation 
in this condition, Further ~tudle~ exploring the intoraotlon between platelets 
end the endethallum are needed, a~ the presence oi endothallal dysfunction in 
atrial fibrillation may contribute to the high risk o1 stroke and thrembcembollsm 
In this condition, 
~ L e f t  Ventrlcular Smoke: An Echocardlographlc 
Study 
L, Baruch, P, O'Dwyer, X. Fann, P. Patacsil, S. Guerm, Division of Cam/iology 
Bronx VA Meclical Center, Cardiovascular InsMuh~, Mr. Sinai Hospital, NY, 
NY, USA 
Smoke IS commonly seen during TEE In the left atrium of pts with AFib (severe 
atrial dysfu~tlon) snd Is associated with thremboembellsm The Inclder¢'e 
and correlates of LV smoke are unknown, Embollo events am common In pts 
with congestive heart failure with an annual Incidence of 2-3%, Transthoraclc 
ochocardtography (TTE) using 2-3,5 MHz transducers rarely permits visual. 
Izatton of LV smoke. Higher frequency transducers may permit visualization 
of LV smoke, We evaluated the ability el a high frequency 5 MHz transducer to 
detect LV smoke in 710 consecutive pts who unde~vent TTE, We compared 
the 58 pts with smoke (SEC+) to the 652 pts without smoke (SEC-) with re- 
spect to LV systolic function, 1 ) ejection fraction (El =) and LV diastolic function 
2) tmnsmltrat E/A ratio 3) deceleration time (mace) (DT), 4) pulmonap/vein 
systolic/diastolic ratio (S/D), 4) LV dlastollo dimensions (cm) (LVID), and the 
i~tdence of thrombl. 58 pts (8%) had LV smoke. 
Age EF% LVID (cm'l DT (msec) Thmrnbt 
SEC.¢. 636 37.8 5.6 178.3 34% 
9EC - 61 O 559 50 217.3 0 
p <O001 <0001 0.003 0.004 0.2 
Pts with smoke have greater systolic and diastolic dysfunction as mani- 
fested by lower election fractions, larger internal diameters, greater EIA and 
lower S/D than those without smoke, No significant difference in the incidence 
of thrembl '.vas noted, 
Conclusion: The clinical significance el LV smoke, its association with 
embolic events (as In AFih), and the potential benefit of anticoagulants Jn pts 
with CHF and LV smoke needs to be determined. 
• Trsnsssophsgul E¢hocerdlogrsphy Considerably 
Impacts the Management of Petlsnte With Stroke, 
Transient lachemlc Attack or  Peripheral Embol ism 
A,M,A, Hasnle, M.F, Stodderd. N. Calzada, R,A, Longeker, University of 
Louisville, LoulsWlle, KY, USA 
of pts with potential emb~ lie events, such as non, hamorraghlo stroke (CVA), 
transient leahamlo eftaok ~IA) or peripheral embolism is contmvemlel, 
Mefttco~: Thus, 155 o0nseoutlve pie (mean ego 6t ~ 14 ym: t02 
F) undergoing TEE for w~rk.up of CVA (n - 90) TIA (n - 37) er PE (n ~, 28) 
were enrolled, Medical ©harts were reviewed to dotermll~ the Influen~-~ of 
TEE msultl on treatment end further In.hospital work-up, TEE wu amx~,mtd 
for the presence el intmcerdloo thmmbus, spontaneous eehe contmM ($EG), 
septlll deleet, loll,sided v;getotlon, aertio plaqge (~5 mm or m~to), ~tqmt 
foreman ovule (grade ,. 2) end valvular flbdn etmn~, 
Roast:TEE was dlegnoatio f e potential emballo souse in S'/% (n = 89) 
of the entire study population a~l In 58% (n =, 52) ul ,i~ CVA, 57% (n = ~t) 
of the TIA end 51% (n ,~ 16) oi the PE group (p = ns), TEE multlz changed 
medloetion (n =J 44) ot suRiiolll (n ,, 1) treatment in ~Ig% (n ,~ 45) and altered 
planned dlognolttio studies In 15% (n = 24) el patients, Ant~agulation with 
warladn Wall alerted in 14% (n =~ 21 ) on lhe basis of TEElindinge ol intmcardla¢ 
thrombus (n = 17), dense left atH= SEC (o ,, 2), widely patenl foremen ovale 
membrane (n = 1) or numemue fib~n Strands (n ~ 1 ), Asl~rin was sladN~l m 
(n = 14) for fibrin strands, In 5% (n = 7) antibiOtl~ were started on the basis el 
TEE findings el tell,sided vegetation and subsequent positive blood cuffum 
(n ,~ 5), Them were no signitioent diltomp¢es in tha change in treatment o~ 
work.up among the stroke, transient isct~mie agack or perild~erel mb~tsm 
greu~s, In 71P,~ (112/155) el pt~, TEE hndlngs el thmmbus, SEC or ~;Iht,to,lelt 
shunt oenlln~ced as al~repdate the empld~ de~slen made ~ to TEE, to 
anttco~gulate (65%; 1 l i t  7) or not to anticoagulate ('~ .%; 10lit 38) (p,- 0,004). 
Conc!us/ons: These data am consistent will1 a significant impact ot TEE 
on the clinical management ol patients with potential ambel¢ events. Future 
studies addressing the effectiveness of treatment, guided by TEE findings, in 
the prevention of recurrent embol~ evenle are needed. 
• Tlclopldlne Activity on Spontaneous 
E©hoaontrast: A 11ranseeophageai 
Echocardlographl© Study 
C P.aiati, O. Cacratta, F. Canata, S. llicoto, P. Rizzon. "S. Maugen" 
Foundation, Division of Car#,olo~, Cassano Murge: Institute of Cam~y.  
Universi(y of Caglmn and Ban, Italy 
Background: Spontaneous echocontrast (SEC) in the left atnum is deemed 
to be a risk factor for penpherel thmmboembolism Itis possible that platelet 
aggregation can play a role in the genesis of SEC. Therefore. the aim ol this 
study was to veery whether Tlclopidine (TIC), a powedul antiplatelet agent. 
could suppress or attenuate the SEC density in the left atoum. 
Methods: For this pulpose, a phase II clinical thai (two-siege descjn) was 
undertaken. In the first stage, 12 patients wflh non valvular atrial libnllation 
and stable SEC density in the left affium as assessed by transeeophageal 
echocardiography (TEE), received Tlclopidice, 500 rag/day, for 2 weeks. At 
the end of the 14-day treatment a further TEE study was performed. Before 
TIC treatment was initiated, the stability of SEC density was detenmined by 
repeating the TEE evaluation after 14 days from the first TEE screening study. 
In each patient !he gain seffing, optimized in the first study, was kept un- 
changed in the further 2 studies. SEC density was scored by the consensus of 
two expedenced observers, as being absent, mild, moderate or severe. The 
TEE-study rea, !ing was perforated in a blinded manner. 
Results: Tlctopidlne was well tolerated. Before TIC. SEC density was 
scored as being mild in 7 cases (58%), moderate in 1 case (8%) and severe in 
4 cases (33%). After TIC, the score remained unchanged, the response rate 
being zero. Therefore, Ticlopidine did not modify the SEC density in the left 
atdum at all in the first stage of the trial. For this reason, in accordance with 
the study design, the second stage was not undertaken. 
Conclusion: in this phase II clinical thai, antiplatelet treatment, using Ticlo- 
pidine 500 rag/day, was ineffective in abolishing or in reducing the SEC density 
in the left atnum. Platelet aggregation, therefore, does not seem to play a role 
in the genesis of spontaneous echocontrast. 
